Skip Navigation


Carcinogenesis Advance Access originally published online on November 4, 2006
Carcinogenesis 2007 28(4):777-784; doi:10.1093/carcin/bgl211
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/4/777    most recent
bgl211v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tambe, Y.
Right arrow Articles by Inoue, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tambe, Y.
Right arrow Articles by Inoue, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs

Yukihiro Tambe1,{dagger}, Atsuko Yoshioka-Yamashita1,11,{dagger}, Ken-ichi Mukaisho2, Seiki Haraguchi1,12, Tokuhiro Chano3, Takahiro Isono4, Takao Kawai5, Yasuhiko Suzuki6, Ryoji Kushima7, Takanori Hattori2, Motohito Goto8, Shuichi Yamada9, Makoto Kiso10, Yumiko Saga10 and Hirokazu Inoue1,*

1 Department of Microbiology, Shiga University of Medical Science Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan
2 Department of Pathology, Shiga University of Medical Science Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan
3 Clinical Laboratory Medicine, Shiga University of Medical Science Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan
4 Central Research Laboratory, Shiga University of Medical Science Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan
5 Department of Infectious Diseases, Osaka Prefectural Institute of Public Health Nakamichi, Higashinari-ku, Osaka, Osaka 537-0025, Japan
6 Department of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University N18, W9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan
7 Division of Diagnostic Pathology, Shiga University of Medical Science Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan
8 SPOC Inc, Reading Venture Plaza 5F 75-1, Ono-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0046, Japan
9 Animal Research Laboratory, Bioscience Education-Research Center, Akita University 1-1-1 Hondo, Akita, Akita 010-8543, Japan
10 Division of Mammalian Development, National Institute of Genetics Yata 1111, Mishima, Shizuoka 411-8540, Japan
11Present address: Moores UCSD Cancer Center, University of California San Diego, School of Medicine 3855 Health Sciences Drive, La Jolla, CA 92093-0820, USA
12Present address: Chiba Cancer Center Research Institute 666-2 Nitona, Chuoh-ku, Chiba 260-717, Japan

*To whom correspondence should be addressed. Tel: +81 77 548 2177; Fax: +81 77 548 2404; Email: hirokazu{at}belle.shiga-med.ac.jp

The drs gene was originally isolated as a suppressor of v-src transformation. Expression of drs mRNA is markedly downregulated in a variety of human cancer cell lines and tissues, suggesting the potential role of this gene as a tumor suppressor. Previously, we found that Drs protein associates with ASY/Nogo-B/RTN-xS, an apoptosis-inducing protein in the endoplasmic reticulum, and sequentially activates caspases to induce apoptosis in human cancer cells without involvement of the mitochondria. In this study, we investigated the tumor suppressor function of drs and the correlation between Drs-mediated apoptosis and tumor suppression by generating a gene-knockout (KO) mouse. Between 7 and 12 months after birth, malignant tumors including lymphomas, lung adenocarcinomas and hepatomas were generated in about 30% of the drs KO mice, whereas no tumors were found in any of the wild-type mice during the same period of time. drs KO embryonic fibroblasts also showed enhanced sensitivity to transformation by v-src oncogene. Reintroduction of drs into a tumor cell line derived from the tumor of a drs KO mouse led to the suppression of tumor formation in nude mice, which was accompanied by enhanced apoptosis and the activation of caspase-9 and -3. Furthermore, introduction of drs into this cell line enhanced sensitivity to apoptosis mediated by caspase-3, -9 and -12 under low serum culture conditions. The present results thus indicate that drs contributes to the suppression of malignant tumor formation, and this suppression is closely correlated with drs-mediated apoptosis.

Abbreviations: KO, knockout; ER, endoplasmic reticulum.


{dagger}These authors contributed equally to this work.

Received August 24, 2006; revised October 21, 2006; accepted October 24, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Ria, K. Todoerti, S. Berardi, A. M. L. Coluccia, A. De Luisi, M. Mattioli, D. Ronchetti, F. Morabito, A. Guarini, M. T. Petrucci, et al.
Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
Clin. Cancer Res., September 1, 2009; 15(17): 5369 - 5378.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Minami, Y. Tambe, R. Watanabe, T. Isono, M. Haneda, K.-i. Isobe, T. Kobayashi, O. Hino, H. Okabe, T. Chano, et al.
Suppression of Viral Replication by Stress-Inducible GADD34 Protein via the Mammalian Serine/Threonine Protein Kinase mTOR Pathway
J. Virol., October 15, 2007; 81(20): 11106 - 11115.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.